retatrutide phase 3 trial dosage TRIUMPH-4 Results: 28.7% Weight Loss & What It Means for the Peptide Industry retatrutide dosage weight loss clinical

In some cases, patients may discuss combining therapies as part of a physician-supervised wellness plan

In recent years, some of these drugs have also been approved to treat obesity and for weight loss

Instead of titrating to the full doses recommended for obesity treatment (e.g., semaglutide 2.4 mg weekly or tirzepatide up to 15 mg), microdosing involves starting and staying at much lower doses sometimes as low as 0.1 to 0.25 mg per week for semaglutide or even intermittent use

However, the science supporting these supplements is limited and largely preliminary

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes